If the above hypothesis, which is not completely improbable, were true - why go with the placement with GF for Stage 3 expansion funding? They got a very good deal on the placement. As others have stated, perhaps that was the trade-off for renegotiation of the pricing formula? Given the pricing formula was never disclosed (and labelled confidential), renegotiation of it would not theoretically trigger a market sensitive announcement. In addition, the short selling is not specific to PLS, but a sector wide phenomenon. They are clearly betting on the macro rather than the micro.
Dial in details 25.1.19 Quarterly, page-77
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.88 |
Change
-0.040(1.37%) |
Mkt cap ! $8.673B | |||
| Open | High | Low | Value | Volume |
| $2.93 | $2.96 | $2.88 | $50.87M | 17.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 127610 | $2.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.90 | 103550 | 8 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PLS (ASX) Chart |